iSpecimen Inc. Additional Paid in Capital
iSpecimen Inc. (ISPC) had Additional Paid in Capital of $87.72 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent › Additional Paid in Capital
us-gaap:AdditionalPaidInCapital · last filed 2026-08-14
- 2026-06-30: Additional Paid in Capital $87.72M.
- 2026-03-31: Additional Paid in Capital $85.44M.
- 2025-12-31: Additional Paid in Capital $85.44M; Additional Paid in Capital as first filed $85.44M.
- 2024-12-31: Additional Paid in Capital $75.17M.
| Period end | Additional Paid in Capital | Additional Paid in Capital as first filed |
|---|---|---|
| 2026-06-30 | $87.72M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $85.44M 10-Q · filed 2026-05-18 | |
| 2025-12-31 | $85.44M 10-Q · filed 2026-08-14 | $85.44M 10-K · filed 2026-04-01 |
| 2024-12-31 | $75.17M 10-K · filed 2026-04-01 | |
| 2024-09-30 | $70.53M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $70.46M 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $69.08M 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $69.11M 10-K · filed 2025-04-14 | $69.10M 10-K · filed 2024-03-13 |
| 2023-09-30 | $69.00M 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $68.89M 10-Q · filed 2023-08-02 | |
| 2023-03-31 | $68.76M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $68.57M 10-K · filed 2024-03-13 | |
| 2022-09-30 | $68.53M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $68.31M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $68.07M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $67.81M 10-K/A · filed 2023-03-30 | |
| 2021-09-30 | $48.06M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $45.09M 10-Q · filed 2021-08-10 | |
| 2020-12-31 | $1.78M 10-K · filed 2022-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |